Sarah Brockbank

Strategy Leader - Complex Medicines

Sarah Brockbank leads the strategy for Complex Medicines at Medicines Discovery Catapult.

In this role she draws on internal expertise and the external environment, through membership of national programmes and a portfolio of client projects, to develop and implement a core strategy for complex medicines that is responsive to the needs of this emerging area.

Sarah has 35 years’ of experience in the pharmaceutical industry. She is a molecular biologist with a focus mainly in target identification & validation and has worked across a broad range of disease areas. Sarah was a Drug Discovery Project Leader at AstraZeneca, and she also has extensive experience in the leadership and management of large public-private consortia and collaborations.